Suven Pharmaceuticals (BOM:543064) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Suven Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Suven Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was ₹2,529 Mil. Therefore, Suven Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Suven Pharmaceuticals's current FCF Yield % is 1.86%.

The historical rank and industry rank for Suven Pharmaceuticals's FCF Margin % or its related term are showing as below:

BOM:543064' s FCF Margin % Range Over the Past 10 Years
Min: -1.74 Med: 23.75 Max: 37.57
Current: 29.17

During the past 6 years, the highest FCF Margin % of Suven Pharmaceuticals was 37.57%. The lowest was -1.74%. And the median was 23.75%.

BOM:543064's FCF Margin % is ranked better than
96.09% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 0.49 vs BOM:543064: 29.17

Suven Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Suven Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals FCF Margin % Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

37.57

27.73

19.76

12.78

29.17

Suven Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Suven Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suven Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Suven Pharmaceuticals's FCF Margin % falls into.

Suven Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Suven Pharmaceuticals's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	3066.962	/	10513.537
	=	29.17 %

Suven Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	2529.303
	=	0.00 %

Suven Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals (BOM:543064) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » FCF Margin %

Traded in Other Exchanges

SUVENPHAR:India

Address

3rd Floor, Road No. 5, Avenue 7, Banjara Hills, No. 8-2-334, SDE Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.

Suven Pharmaceuticals (BOM:543064) Headlines

No Headlines